# OnCo record paper-asco-cap-er-pr-testing-guideline-jco-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-asco-cap-er-pr-testing-guideline-jco-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-asco-cap-er-pr-testing-guideline-jco-2010" ;
  schema:name "American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer"@en ;
  schema:description "The 2010 rule that fixed the line between hormone receptor-positive and negative breast cancer at 1 percent of stained tumour nuclei, after finding that up to a fifth of receptor tests worldwide might be wrong; it is the threshold that defines triple-negative disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-asco-cap-er-pr-testing-guideline-jco-2010/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2009.25.6529>, <https://pubmed.ncbi.nlm.nih.gov/20404251/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2009.25.6529> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Hammond ME, Hayes DF, Dowsett M, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/digital-pathology-ai/> ;
  onco:institutions <https://onco.cc/institutions/asco/> ;
  onco:terms <https://onco.cc/terms/ihc/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:journals <https://onco.cc/journals/jco/> .